Transgene Biotek Limited (BOM:526139)
India · Delayed Price · Currency is INR 2.760
+0.050 (1.85%)
At close: Sep 16, 2026
Transgene Biotek Revenue
Transgene Biotek had revenue of 600.00K INR in the quarter ending June 30, 2026, with 21.21% growth. This brings the company's revenue in the last twelve months to 2.22M, down -15.06% year-over-year. In the fiscal year ending March 31, 2026, Transgene Biotek had annual revenue of 2.11M, down -18.99%.
Revenue (ttm)
2.22M
Revenue Growth
-15.06%
P/S Ratio
92.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
205.34M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.11M | -495.00K | -18.99% |
| Mar 31, 2025 | 2.61M | 258.00K | 10.98% |
| Mar 31, 2024 | 2.35M | 1.80M | 326.32% |
| Mar 31, 2023 | 551.00K | -315.95K | -36.44% |
| Mar 31, 2022 | 866.95K | -828.55K | -48.87% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Neeraj Paper Marketing | 1.66B |
| Uniroyal Industries | 1.21B |
| Hisar Spinning Mills | 441.09M |
| Jayshree Chemicals | 232.44M |
| Rapid Investments | 20.81M |
| Pro Clb Global | 14.41M |
| South Asian Enterprises | 4.02M |
| Polo Hotels | 2.24M |